Flow Diversion of Posterior Circulation Aneurysms: Systematic Review of Disaggregated Individual Patient Data

References

1. 1.↵
   1. Chancellor B,
   2. Raz E,
   3. Shapiro M, et al

   . Flow diversion for intracranial aneurysm treatment: trials involving flow diverters and long-term outcomes. Neurosurgery 2020;86:S36–45 doi:10.1093/neuros/nyz345 pmid:31838533

   CrossRefPubMed
2. 2.↵
   International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: risk of rupture and risks of surgical intervention. N Engl J Med 1998;339:1725–33 doi:10.1056/NEJM199812103392401 pmid:9867550

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Pumar JM,
   2. Garcia-Dorrego R,
   3. Nieto A, et al

   . Vascular reconstruction of a fusiform basilar aneurysm with the Silk embolization system. J Neurointerv Surg 2010;2:242–44 doi:10.1136/jnis.2010.002725 pmid:21990634

   Abstract/FREE Full Text
4. 4.↵
   1. Fiorella D,
   2. Kelly ME,
   3. Albuquerque FC, et al

   . Curative reconstruction of a giant midbasilar trunk aneurysm with the Pipeline Embolization Device. Neurosurgery 2009;64:212–17; discussion 217 doi:10.1227/01.NEU.0000337576.98984.E4 pmid:19057425

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Klisch J,
   2. Turk A,
   3. Turner R, et al

   . Very late thrombosis of flow-diverting constructs after the treatment of large fusiform posterior circulation aneurysms. AJNR Am J Neuroradiol 2011;32:627–32 doi:10.3174/ajnr.A2571 pmid:21436336

   Abstract/FREE Full Text
6. 6.↵
   1. Fiorella D,
   2. Hsu D,
   3. Woo HH, et al

   . Very late thrombosis of a Pipeline Embolization Device construct: case report. Neurosurgery 2010;67:onsE313–14; discussion onsE314 doi:10.1227/01.NEU.0000383875.08681.23 pmid:20679914

   CrossRefPubMed
7. 7.↵
   1. Siddiqui AH,
   2. Abla AA,
   3. Kan P, et al

   . Panacea or problem: flow diverters in the treatment of symptomatic large or giant fusiform vertebrobasilar aneurysms. J Neurosurg 2012;116:1258–66 doi:10.3171/2012.2.JNS111942 pmid:22404673

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Wiebers DO,
   2. Whisnant JP,
   3. Huston J 3rd.

   et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003;362:103–10 doi:10.1016/S0140-6736(03)13860-3 pmid:12867109

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Raaymakers TW,
   2. Rinkel GJ,
   3. Limburg M, et al

   . Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke 1998;29:1531–38 doi:10.1161/01.str.29.8.1531 pmid:9707188

   Abstract/FREE Full Text
10. 10.↵
    1. Liang F,
    2. Zhang Y,
    3. Yan P, et al

    . Outcomes and complications after the use of the Pipeline Embolization Device in the treatment of intracranial aneurysms of the posterior circulation: a systematic review and meta-analysis. World Neurosurg 2019;127:e888–95 doi:10.1016/j.wneu.2019.03.291 pmid:30959253

    CrossRefPubMed
11. 11.↵
    1. Moher D,
    2. Liberati A,
    3. Tetzlaff J, et al

    . The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097 doi:10.1371/journal.pmed.1000097 pmid:19621072

    CrossRefPubMed
12. 12.↵
    1. Albuquerque FC,
    2. Park MS,
    3. Abla AA, et al

    . A reappraisal of the Pipeline Embolization Device for the treatment of posterior circulation aneurysms. J Neurointerv Surg 2015;7:641–45 doi:10.1136/neurintsurg-2014-011340 pmid:25092926

    Abstract/FREE Full Text
13. 13.↵
    1. Bender MT,
    2. Colby GP,
    3. Jiang B, et al

    . Flow diversion of posterior circulation cerebral aneurysms: a single-institution series of 59 cases. Neurosurgery 2019;84:206–16 doi:10.1093/neuros/nyy076 pmid:29608702

    CrossRefPubMed
14. 14.↵
    1. Griessenauer CJ,
    2. Ogilvy CS,
    3. Adeeb N, et al

    . Pipeline embolization of posterior circulation aneurysms: a multicenter study of 131 aneurysms. J Neurosurg 2018;130:923–35 doi:10.3171/2017.9.JNS171376 pmid:29726768

    CrossRefPubMed
15. 15.↵
    1. Liang F,
    2. Zhang Y,
    3. Guo F, et al

    . Use of Pipeline Embolization Device for posterior circulation aneurysms: single-center experiences with comparison with anterior circulation aneurysms. World Neurosurg 2018;112:e683–90 doi:10.1016/j.wneu.2018.01.129 pmid:29410337

    CrossRefPubMed
16. 16.↵
    1. Lopes DK,
    2. Jang DK,
    3. Cekirge S, et al

    . Morbidity and mortality in patients with posterior circulation aneurysms treated with the Pipeline embolization device: a subgroup analysis of the international retrospective study of the Pipeline Embolization Device. Neurosurgery 2018;83:488–500 doi:10.1093/neuros/nyx467 pmid:28945879

    CrossRefPubMed
17. 17.↵
    1. Phillips TJ,
    2. Wenderoth JD,
    3. Phatouros CC, et al

    . Safety of the Pipeline Embolization Device in treatment of posterior circulation aneurysms. AJNR Am J Neuroradiol 2012;33:1225–31 doi:10.3174/ajnr.A3166 pmid:22678845

    Abstract/FREE Full Text
18. 18.↵
    1. Taschner CA,
    2. Vedantham S,
    3. de Vries J, et al

    . Surpass flow diverter for treatment of posterior circulation aneurysms. AJNR Am J Neuroradiol 2017;38:582–89 doi:10.3174/ajnr.A5029 pmid:28007769

    Abstract/FREE Full Text
19. 19.↵
    1. Adeeb N,
    2. Ogilvy CS,
    3. Griessenauer CJ, et al

    . Expanding the indications for flow diversion: treatment of posterior circulation aneurysms. Neurosurgery 2020;86:S76–84 doi:10.1093/neuros/nyz344 pmid:31838535

    CrossRefPubMed
20. 20.↵
    1. Khosla A,
    2. Brinjikji W,
    3. Cloft H, et al

    . Age-related complications following endovascular treatment of unruptured intracranial aneurysms. AJNR Am J Neuroradiol 2012;33:953–57 doi:10.3174/ajnr.A2881 pmid:22241386

    Abstract/FREE Full Text
21. 21.↵
    1. Chalouhi N,
    2. Tjoumakaris S,
    3. Phillips JL, et al

    . A single Pipeline Embolization Device is sufficient for treatment of intracranial aneurysms. AJNR Am J Neuroradiol 2014;35:1562–66 doi:10.3174/ajnr.A3957 pmid:24788125

    Abstract/FREE Full Text
22. 22.↵
    1. Waqas M,
    2. Vakharia K,
    3. Gong AD, et al

    . One and done? The effect of number of Pipeline embolization devices on aneurysm treatment outcomes. Interv Neuroradiol 2020;26:147–55 doi:10.1177/1591019919888130 pmid:31766960

    CrossRefPubMed
23. 23.↵
    1. Kobayashi N,
    2. Murayama Y,
    3. Yuki I, et al

    . Natural course of dissecting vertebrobasilar artery aneurysms without stroke. AJNR Am J Neuroradiol 2014;35:1371–75 doi:10.3174/ajnr.A3873 pmid:24610902

    Abstract/FREE Full Text
24. 24.↵
    1. Saliou G,
    2. Sacho RH,
    3. Power S, et al

    . Natural history and management of basilar trunk artery aneurysms. Stroke 2015;46:948–53 doi:10.1161/STROKEAHA.114.006909 pmid:25712945

    Abstract/FREE Full Text
25. 25.↵
    1. Sonmez O,
    2. Brinjikji W,
    3. Murad MH, et al

    . Deconstructive and reconstructive techniques in treatment of vertebrobasilar dissecting aneurysms: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2015;36:1293–98 doi:10.3174/ajnr.A4360 pmid:25953763

    Abstract/FREE Full Text
26. 26.↵
    1. Sanai N,
    2. Tarapore P,
    3. Lee AC, et al

    . The current role of microsurgery for posterior circulation aneurysms: a selective approach in the endovascular era. Neurosurgery 2008;62:1236–49; discussion 1249–53 doi:10.1227/01.neu.0000333295.59738.de pmid:18824990

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Kim BM,
    2. Kim SH,
    3. Kim DI, et al

    . Outcomes and prognostic factors of intracranial unruptured vertebrobasilar artery dissection. Neurology 2011;76:1735–41 doi:10.1212/WNL.0b013e31821a7d94 pmid:21576691

    CrossRefPubMed
28. 28.↵
    1. Guan J,
    2. Li G,
    3. Kong X, et al

    . Endovascular treatment for ruptured and unruptured vertebral artery dissecting aneurysms: a meta-analysis. J Neurointerv Surg 2017;9:558–63 doi:10.1136/neurintsurg-2016-012309 pmid:27220870

    Abstract/FREE Full Text
29. 29.↵
    1. Drake CG,
    2. Peerless SJ

    . Giant fusiform intracranial aneurysms: review of 120 patients treated surgically from 1965 to 1992. J Neurosurg 1997;87:141–62 doi:10.3171/jns.1997.87.2.0141 pmid:9254076

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Coert BA,
    2. Chang SD,
    3. Do HM, et al

    . Surgical and endovascular management of symptomatic posterior circulation fusiform aneurysms. J Neurosurg 2007;106:855–65 doi:10.3171/jns.2007.106.5.855 pmid:17542530

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Tonetti DA,
    2. Jankowitz BT,
    3. Gross BA

    . Antiplatelet therapy in flow diversion. Neurosurgery 2020;86:S47–52 doi:10.1093/neuros/nyz391 pmid:31838537

    CrossRefPubMed